[1]
D. Betancor, S. Bautista, R. López-Rodríguez, M. Valverde-Monge, M. Fernández-Nieto, and M. J. Rial, “Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics”, Allergol Immunopathol, vol. 52, no. 6, pp. 76–78, Nov. 2024, doi: 10.15586/aei.v52i6.1161.